Sera Prognostics - IR Website

Home

News

Month Year

Investor Alerts

December 15

SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX

Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients,...

Read More
December 02

SERA PROGNOSTICS ANNOUNCES PRICING FOR PRETRM® TEST, THE ONLY BROADLY VALIDATED BLOOD TEST TO ASSESS RISK OF PRETERM BIRTH

– New Assigned Rate Further Validates the Commercial Value of the PreTRM® Test –

Salt Lake City – Dec 2, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...

Read More
December 01

SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA CONFIRMING THE PERFORMANCE OF THE IBP4/SHBG BIOMARKERS IN DIVERSE NON-U.S. POPULATIONS

Results confirmed that a U.S. validated proteomics predictor could be applied in low and middle income countries to help address global preterm birth challenges

Salt Lake City, – December 1, 2021 – Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

Read More
November 30

SERA PROGNOSTICS ANNOUNCES THE APPOINTMENT OF SANDRA A. J. LAWRENCE TO THE SERA PROGNOSTICS BOARD

– Highly respected healthcare and financial leader joins Sera in its quest to improve pregnancy outcomes of mothers and babies –

Salt Lake City, Nov. 30, 2021 (PR NEWSWIRE) — Sera PrognosticsInc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...

Read More
November 09

SERA PROGNOSTICS REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS

Salt Lake City – November 9, 2021 – Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...

Read More

Show per page

Email Alerts